Literature DB >> 8142374

Nitrous oxide inactivation of cobalamin-dependent methionine synthase from Escherichia coli: characterization of the damage to the enzyme and prosthetic group.

J T Drummond1, R G Matthews.   

Abstract

Nitrous oxide, or laughing gas, is an anaesthetic agent that inactivates cobalamin-dependent methionine synthase. This enzyme uses the highly reactive, enzyme-bound cob(I)alamin oxidation state of the prosthetic group to effect methyl group transfer from 5-methyltetrahydrofolate to homocysteine to form tetrahydrofolate and methionine. The cob(I)alamin is capable of reductively degrading nitrous oxide, and here we characterize the modifications that occur to the Escherichia coli enzyme following electrochemical inactivation. Methionine synthase was inactivated on a milligram scale by equilibrating enzyme containing bound cob(II)alamin with a reduced electrochemical mediator to give the reactive cob(I)alamin state under an anaerobic atmosphere of nitrous oxide. The primary damage occurs to a 37.2-kDa domain that binds S-adenosylmethionine (AdoMet), and inactive enzyme can no longer be reductively methylated using AdoMet. The damage is oxidative, and it includes the covalent addition of the mediator, triquat, to the enzyme selectively at valine 1177, as well as the formation of a covalent cross-link between peptides containing the only two cysteines within this domain. Spectrally, the prosthetic group bound to inactive enzyme resembles cob(II)alamin, although some loss in absorbance is apparent. When the enzyme was reconstituted with [57Co]cobalamin and the inactivation repeated, the cobalamin was recovered unmodified in approximately 75% yield, but two products derived from the cobalamin were also observed. We interpret the finding of oxidatively modified products as strong evidence that reductive degradation of nitrous oxide releases a potent oxidant, presumably hydroxyl radical or its equivalent, that is capable of modifying sites proximal to the cobalamin.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8142374     DOI: 10.1021/bi00178a034

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  7 in total

1.  INDISIM-Denitrification, an individual-based model for study the denitrification process.

Authors:  Pablo Araujo-Granda; Anna Gras; Marta Ginovart; Vincent Moulton
Journal:  J Ind Microbiol Biotechnol       Date:  2019-11-05       Impact factor: 3.346

2.  Anaerobic chlorophyll isocyclic ring formation in Rhodobacter capsulatus requires a cobalamin cofactor.

Authors:  S P Gough; B O Petersen; J O Duus
Journal:  Proc Natl Acad Sci U S A       Date:  2000-06-06       Impact factor: 11.205

3.  Co-ordinate variations in methylmalonyl-CoA mutase and methionine synthase, and the cobalamin cofactors in human glioma cells during nitrous oxide exposure and the subsequent recovery phase.

Authors:  B Riedel; T Fiskerstrand; H Refsum; P M Ueland
Journal:  Biochem J       Date:  1999-07-01       Impact factor: 3.857

Review 4.  Volatile substance misuse: an updated review of toxicity and treatment.

Authors:  Jonathan B Ford; Mark E Sutter; Kelly P Owen; Timothy E Albertson
Journal:  Clin Rev Allergy Immunol       Date:  2014-02       Impact factor: 8.667

5.  Metabolic evidence of vitamin B-12 deficiency, including high homocysteine and methylmalonic acid and low holotranscobalamin, is more pronounced in older adults with elevated plasma folate.

Authors:  Joshua W Miller; Marjorie G Garrod; Lindsay H Allen; Mary N Haan; Ralph Green
Journal:  Am J Clin Nutr       Date:  2009-09-02       Impact factor: 7.045

6.  Endocrine disruption: Battle ground for anesthesia.

Authors:  Sukhminder Jit Singh Bajwa; Sanjay Kalra
Journal:  Anesth Essays Res       Date:  2015 Jan-Apr

7.  Copper control of bacterial nitrous oxide emission and its impact on vitamin B12-dependent metabolism.

Authors:  Matthew J Sullivan; Andrew J Gates; Corinne Appia-Ayme; Gary Rowley; David J Richardson
Journal:  Proc Natl Acad Sci U S A       Date:  2013-11-18       Impact factor: 11.205

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.